Kerry D. Ingalls - Nov 17, 2021 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Chief Operating Officer
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
Stock symbol
PSTX
Transactions as of
Nov 17, 2021
Transactions value $
$14,000
Form type
4
Date filed
11/18/2021, 08:12 PM
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Purchase $14K +2K $7.00 2K Nov 17, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.